The Medicine Maker

In this issue, our cover features looks at the mRNA field – asking what lies ahead for mRNA post-pandemic, featuring contributions from CureVac, Sartorius, and more. We also speak with the Drugs for Neglected Diseases initiative to learn about a partnership that brought a new hep C treatment to Malaysia. In In My View, we cover advanced therapies, rapid-dissolve tablet technologies, and the pharma supply chain. We also sit down with Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) at the FDA.

Download PDF

Manufacture Business & Trends Small Molecules Bioprocessing Biopharma Outsourcing Technology & Manufacturing Formulation Drug Delivery

Crafting a Magic Bullet

October 5, 2021

The field of antibody drug conjugates has seen many ups and downs, but, with new science shedding light on how to better design and engineer these therapies, it’s certainly never boring. Colin McKee, Head of Technical Services at Sterling Pharma Solutions, gets us up to speed on advances shaping this dynamic space.

1 min read

Manufacture Outsourcing Technology & Manufacturing Business & Trends Sponsored

Tackling the High-Potency Trend

September 29, 2021

The increased emphasis on oncology drug development has led to rising demand for experienced service providers able to handle HPAPIs from development through to full scale commercialization. Here, Rebecca Coutts, General Manager of PCI Tredegar, discusses how to safely work with these highly potent – and often life-saving – drug substances

1 min read

Discovery & Development Regulation & Standards Business & Trends Supply Chain

Comirnaty for the Community?

September 27, 2021

Pfizer-BioNTech’s COVID-19 vaccine has received full FDA approval

1 min read

Manufacture Cell & Gene Outsourcing Drug Discovery Research News

mRNA: Reaching for the Sun

September 24, 2021

The mRNA field is experiencing rapid growth in the wake of pandemic success, but what more needs to be done to ensure it truly flourishes?

1 min read

Manufacture Outsourcing Technology & Manufacturing Facilities & Equipment

Lonza’s Cantonese Dream

September 21, 2021

The Swiss firm continues investment in China with a manufacturing upgrade to its key Guangzhou site

1 min read

Manufacture Bioprocessing Biopharma Small Molecules Business & Trends Cell & Gene Sponsored

The Rise of mRNA: New Era, New Challenges

September 21, 2021

mRNA vaccines have provided one good answer to humankind’s latest grand challenge, but the technology has yet to mature. If the success story of these nucleotide-based drugs is to continue, manufacturers must look to ease the headaches associated with their manufacture.

1 min read

The Rise of mRNA: New Era, New Challenges

Business & Regulation Regulation & Standards Business & Trends Development & Clinical Facilities & Equipment

Of Medicine and Machine Learning

September 15, 2021

How should regulators approach the challenge of regulating AI?

1 min read

Discovery & Development Development & Clinical Business & Trends Small Molecules

Malaysia in the Middle: Tackling Hep C in an Unfair World

September 9, 2021

How the Drugs for Neglected Diseases Initiative worked successfully with local and global partners to improve left-behind lives in Southeast Asia

1 min read

Malaysia in the Middle: Tackling Hep C in an Unfair World

Manufacture Facilities & Equipment Technology & Manufacturing Bioprocessing Biopharma Regulation & Standards Sponsored

Now You See It

September 6, 2021

What are the challenges and best practices in quality control for difficult-to-inspect products?

1 min read

Manufacture Formulation Small Molecules Drug Delivery Outsourcing Sponsored

A Nice Cup of RDT

September 3, 2021

Rapid-dissolve tablet technologies offer immense benefits, but the pharma industry has yet to fully realize their potential

1 min read

Manufacture Small Molecules Business & Trends Supply Chain Sponsored

(Precious) Metal Will Never Die

September 2, 2021

Precious metals-bearing catalysts are essential in some pharma processes – but, once they’re spent, they still hold value. Here, Brad Cook, Vice President of Sales and Marketing at Sabin Metals, reminds us that not all catalysts – and not all recyclers – are the same.

1 min read

Discovery & Development Drug Discovery Research News Sponsored

Archived Antivirals

August 31, 2021

Longstanding treatments for tapeworm could take on COVID-19

1 min read

Manufacture Supply Chain Drug Discovery Research News

Moving Beyond Clinical Manufacturing

August 26, 2021

There is a critical need to focus on the supply chain approach to help enable the cell and gene therapy field to achieve full bloom. We must ask ourselves: what and where are the pain points, how can we resolve them, and finally, how can we streamline the overall process?

1 min read

Manufacture Drug Discovery Research News Development & Clinical Cell & Gene Bioprocessing Biopharma Supply Chain

Bringing Certainty to CAR T-Cell Discovery

August 20, 2021

How do we get closer to perfection? It starts with looking at the complete picture

1 min read

Bringing Certainty to CAR T-Cell Discovery

Business & Regulation Regulation & Standards Business & Trends Development & Clinical Sponsored

The Winding Road to the Frontline for Advanced Therapies

July 30, 2021

Four major considerations in easing the process of taking ATMPs to clinical trials

1 min read

September 2021

Crafting a Magic Bullet

Tackling the High-Potency Trend

Comirnaty for the Community?

mRNA: Reaching for the Sun

Lonza’s Cantonese Dream

The Rise of mRNA: New Era, New Challenges

Of Medicine and Machine Learning

Malaysia in the Middle: Tackling Hep C in an Unfair World

Now You See It

A Nice Cup of RDT

(Precious) Metal Will Never Die

Archived Antivirals

Moving Beyond Clinical Manufacturing

Bringing Certainty to CAR T-Cell Discovery

The Winding Road to the Frontline for Advanced Therapies

Recommended

Recent Issues

Explore

Featured Topics

Issues

Topics

News & Blogs

Community & Awards

September 2021

Recommended

Recent Issues